Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1231-1240 of 1,339) with videos related to

Pageof 134
Sort By:
Cell Reports|March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastomaMiller Huang, Wanqi Fang, Alvin Farrel, et al.
Cell Reports|August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastomaMiriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.
Journal of Critical Care|April 3, 2016
Key stakeholders' perceptions of the acceptability and usefulness of a tablet-based tool to improve communication and shared decision making in ICUsNatalie C Ernecoff, Holly O Witteman, Kristen Chon, et al.
JCI Insight|October 5, 2016
<i>IL1RL1</i> asthma risk variants regulate airway type 2 inflammationErin D Gordon, Joe Palandra, Agata Wesolowska-Andersen, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Steven G DuBois, Araz Marachelian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Pediatric Blood & Cancer|April 11, 2019
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 studySteve E Braunstein, Wendy B London, Susan G Kreissman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Intensive Care Medicine|July 28, 2018
Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient dataMatthieu Jabaudon, Raiko Blondonnet, Bruno Pereira, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2020
Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in SheepJonathan E Millar, Nicole Bartnikowski, Margaret R Passmore, et al.
Pageof 134

Showing results (1231-1240 of 1,339) with videos related to

Sort By:
Pageof 134
Cell Reports|March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastomaMiller Huang, Wanqi Fang, Alvin Farrel, et al.
Cell Reports|August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastomaMiriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.
Journal of Critical Care|April 3, 2016
Key stakeholders' perceptions of the acceptability and usefulness of a tablet-based tool to improve communication and shared decision making in ICUsNatalie C Ernecoff, Holly O Witteman, Kristen Chon, et al.
JCI Insight|October 5, 2016
<i>IL1RL1</i> asthma risk variants regulate airway type 2 inflammationErin D Gordon, Joe Palandra, Agata Wesolowska-Andersen, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Steven G DuBois, Araz Marachelian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Pediatric Blood & Cancer|April 11, 2019
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 studySteve E Braunstein, Wendy B London, Susan G Kreissman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Intensive Care Medicine|July 28, 2018
Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient dataMatthieu Jabaudon, Raiko Blondonnet, Bruno Pereira, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2020
Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in SheepJonathan E Millar, Nicole Bartnikowski, Margaret R Passmore, et al.
Pageof 134